A Game Changer for Follicular Lymphoma: Mastering Use of Precision Therapies as Part of a Chemo-Free Treatment Paradigm

Deepen your understanding of current and emerging chemo-free treatment strategies for patients with relapsed/refractory follicular lymphoma and learn how to appropriately manage the treatment-related toxicities to maximize outcomes. After the live webinar, view the on-demand webcast, download the associated slideset for use in your clinic, and review the expert-authored answers to frequently asked questions.

Share

Program Content

Activities

Clinical Needs and Targeted Therapies for RR FL
Overview, Unmet Needs, Current Landscape and Treatment With Targeted Therapies in R/R FL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

Bispecific Antibodies in RR FL
Integrating Bispecific Antibodies Into the Treatment of Patients With R/R FL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

CAR T Cell Tx in RR FL
Optimizing CAR T-Cell Therapies in R/R FL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

Faculty

cover img faculity

Caron Jacobson, MD

Associate Professor of Medicine
Harvard Medical School
Medical Director, Immune Effector Cell Therapy Program
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Peter Martin, MD

Professor of Medicine
Weill Cornell Medicine
New York, New York

cover img faculity

Sonali M. Smith, MD, FASCO

Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Co-Leader, Cancer Service Line
The University of Chicago
Chicago, Illinois

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Follicular Lymphoma Foundation.

Supporters

Supported by educational grants from AstraZeneca; Genmab US, Inc.; and Ipsen Biopharmaceuticals, Inc.

AstraZeneca

Genmab US, Inc.

Ipsen Biopharmaceuticals Inc

Partners

Follicular Lymphoma Foundation

ProCE Banner